☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Heron Therapeutics
Heron Therapeutics Launches Aponvie for the Management of Postoperative Nausea and Vomiting in the US
March 7, 2023
Heron Therapeutics’ Aponvie (HTX-019) Receives the US FDA’s Approval for the Prevention of Postoperative Nausea and Vomiting
October 20, 2022
PharmaShots Weekly Snapshots (May 10 - 14, 2021)
May 14, 2021
Load more...
Back to Home
Modal title
×
Modal body text goes here.